Published on Microbicide Trials Network (http://www.mtnstopshiv.org)

Home > MTN-007

MTN-007

A Phase I study designed to determine if rectal use of a reformulated version of tenofovir gel is safe and whether men and women would be willing to use it as a rectal microbicide.
 
See
Reduced Glycerin Formulation of Tenofovir Vaginal Gel Safe for Rectal Use [1]
May 17, 2012
 
Rectal Formulation of Tenofovir Gel Found Safe and Acceptable in Early Phase Clinical Study [2]
Mar 5, 2012
  
Researchers Reformulate Tenofovir Vaginal Gel for Rectal Use [3]
Feb 28, 2011
  
Promising HIV prevention microbicide tenofovir gel in new trial testing safety of rectal use [4]
Oct 13, 2010
      
MTN-007 Backgrounder [5]
  
MTN-007 Q&A [6]
  
Rectal Microbicides [7]
 
See Also
MTN-007 Study Protocol [8]
Printer-friendly version [9]
Source URL: http://www.mtnstopshiv.org/news/studies/mtn007

Links:
[1] http://www.mtnstopshiv.org/node/4496
[2] http://www.mtnstopshiv.org/node/4351
[3] http://www.mtnstopshiv.org/node/2934
[4] http://www.mtnstopshiv.org/node/2336
[5] http://www.mtnstopshiv.org/news/studies/mtn007/backgrounder
[6] http://www.mtnstopshiv.org/news/studies/mtn007/qa
[7] http://www.mtnstopshiv.org/node/2864
[8] http://www.mtnstopshiv.org/sites/default/files/attachments/MTN-007%20Version%202.0_13AUG10_CLEAN.pdf
[9] http://www.mtnstopshiv.org/print/2333

Media Contacts:

Lisa Rossi -- Office: +1 412 641-8940 -- Mobile: +1 412 916-3315 -- Email: rossil@upmc.edu

Clare Collins -- Office: +1 412 641-7299 -- Mobile: +1 412 770-8643 -- Email: collcx@upmc.edu